Squarepoint’s Verona Pharma VRNA Stock Holding History

Squarepoint’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42,229	Closed	-$4.51M	–	4949
2025 Q3	$4.51M	Buy	42,229 +36,670	+660%	+$3.83M	﹤0.01%	1534
2025 Q2	$526K	Sell	5,559 -1,244	-18%	-$92.1K	﹤0.01%	3233
2025 Q1	$432K	Buy	+6,803	New	+$407K	﹤0.01%	3439
2023 Q3	–	Sell	-14,008	Closed	-$296K	–	4291
2023 Q2	$296K	Buy	+14,008	New	+$299K	﹤0.01%	2978

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Squarepoint's VRNA Position: Q4 2025 in Review

Squarepoint sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 42,229 shares — an estimated $4.51M sold.

Squarepoint first reported a position in VRNA in Q2 2023 and held it in 4 quarters. The position peaked at $4.51M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Squarepoint reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 42,229 Verona Pharma shares in Q4 2025, an estimated $4.51M.
Squarepoint first reported a position in Verona Pharma in Q2 2023 and held it in 4 quarters.
Squarepoint's Verona Pharma position peaked at $4.51M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.